HMG-CoA Reductase Inhibitors as Drug Leads against


Journal

ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337

Informations de publication

Date de publication:
07 10 2020
Historique:
pubmed: 4 9 2020
medline: 22 6 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

Primary amebic meningoencephalitis (PAM), caused by the free-living ameba

Identifiants

pubmed: 32881478
doi: 10.1021/acschemneuro.0c00428
pmc: PMC7544672
mid: NIHMS1630834
doi:

Substances chimiques

Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3089-3096

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI133394
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI146460
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM131881
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001444
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI141210
Pays : United States

Références

Antimicrob Agents Chemother. 2003 Feb;47(2):524-8
pubmed: 12543653
ACS Chem Neurosci. 2020 Aug 19;11(16):2464-2471
pubmed: 32392039
Expert Opin Drug Metab Toxicol. 2014 Jan;10(1):51-65
pubmed: 24156555
Front Microbiol. 2018 Mar 06;9:414
pubmed: 29559968
J Pediatr. 2015 Aug;167(2):338-43.e5
pubmed: 26059337
J Atheroscler Thromb. 2018 May 1;25(5):422-429
pubmed: 29187694
Int Heart J. 2018 Sep 26;59(5):1015-1025
pubmed: 30158384
J Parasitol. 2000 Feb;86(1):50-5
pubmed: 10701563
Curr Ther Res Clin Exp. 2015 Mar 03;77:52-7
pubmed: 26082816
J Clin Invest. 1984 Sep;74(3):795-804
pubmed: 6565710
Science. 1992 Jun 5;256(5062):1443-5
pubmed: 1604319
J Mol Biol. 1994 Jan 21;235(3):983-1002
pubmed: 8289329
Arch Neurol. 2011 Nov;68(11):1385-92
pubmed: 22084122
Parasitol Res. 2015 Dec;114(12):4431-9
pubmed: 26329128
Fundam Clin Pharmacol. 2005 Feb;19(1):117-25
pubmed: 15660968
J Biol Chem. 2002 Jun 21;277(25):22353-60
pubmed: 11948186
Antimicrob Agents Chemother. 2015 Nov;59(11):6677-81
pubmed: 26259797
Atheroscler Suppl. 2010 Dec;11(3):3-7
pubmed: 21193152
Pharmacol Rev. 2012 Jan;64(1):102-46
pubmed: 22106090
Exp Parasitol. 2018 May;188:36-41
pubmed: 29551628
Toxicol Sci. 2013 Jul;134(1):73-82
pubmed: 23564645
Exp Neurol. 2010 Dec;226(2):274-84
pubmed: 20816828
PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006104
pubmed: 29284029
J Antimicrob Chemother. 2012 Nov;67(11):2576-97
pubmed: 22833634
Adv Pharmacol. 1998;44:343-500
pubmed: 9547888
Int J Mol Sci. 2019 Jul 19;20(14):
pubmed: 31330988
Parasitol Res. 2014 Aug;113(8):2765-76
pubmed: 24832815
J Clin Invest. 1973 Jun;52(6):1303-13
pubmed: 4703220
Nucleic Acids Res. 2017 Sep 6;45(15):8835-8843
pubmed: 28605514
Antimicrob Agents Chemother. 1976 Aug;10(2):370-6
pubmed: 984777
Antimicrob Agents Chemother. 2012 Nov;56(11):5450-7
pubmed: 22869574
Curr Vasc Pharmacol. 2012 Mar;10(2):257-67
pubmed: 22022768
J Pediatric Infect Dis Soc. 2015 Dec;4(4):e68-75
pubmed: 26582886
Arch Biochem Biophys. 2011 Jan 15;505(2):131-43
pubmed: 20932952
Pharm Res. 1994 Feb;11(2):305-11
pubmed: 8165193
Ann Neurol. 2006 Dec;60(6):729-39
pubmed: 17192930
J Pharmacol Exp Ther. 2005 Feb;312(2):786-93
pubmed: 15358814
PLoS Pathog. 2018 Sep 13;14(9):e1007245
pubmed: 30212566
Annu Rev Biochem. 1999;68:157-85
pubmed: 10872447
J Med Microbiol. 2016 Sep;65(9):885-896
pubmed: 27381464
J Clin Lipidol. 2011 Sep-Oct;5(5):373-9
pubmed: 21981838
J Alzheimers Dis. 2011;23(2):307-18
pubmed: 21098985
ACS Infect Dis. 2019 Dec 13;5(12):2029-2038
pubmed: 31583882
Pediatrics. 2015 Mar;135(3):e744-8
pubmed: 25667249
Pathogens. 2019 Aug 08;8(3):
pubmed: 31398829
Pediatr Neurol. 1996 Oct;15(3):230-4
pubmed: 8916161
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
J Cardiovasc Pharmacol. 1993 Feb;21(2):339-46
pubmed: 7679171

Auteurs

Hye Jee Hahn (HJ)

Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093-0756, United States.

Ruben Abagyan (R)

Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093-0756, United States.

Larissa M Podust (LM)

Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093-0756, United States.

Shantanu Roy (S)

Free-Living and Intestinal Amebas (FLIA) Laboratory, Waterborne Disease Prevention Branch, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia 30329-4018, United States.

Ibne Karim M Ali (IKM)

Free-Living and Intestinal Amebas (FLIA) Laboratory, Waterborne Disease Prevention Branch, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia 30329-4018, United States.

Anjan Debnath (A)

Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093-0756, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH